Effect of therapeutic dose of vitamin D on serum adiponectin and glycemia in vitamin D-insufficient or deficient type 2 diabetic Patients
Joint Authors
Qurbani, Mustafa
Shadman, Zhalah
Baziar, Nima
Jafarian, Kurosh
Nikoo, Muhsin Khushniat
Abd Mishani, Mahshid
Source
Iranian Red Crescent Medical Journal
Issue
Vol. 16, Issue 9 (30 Sep. 2014), pp.1-8, 8 p.
Publisher
Publication Date
2014-09-30
Country of Publication
United Arab Emirates
No. of Pages
8
Main Subjects
Pharmacy, Health & Medical Sciences
Topics
Abstract EN
Background : Lower vitamin D status has been reported in diabetic patients.
Serum 25-hydroxyvitamin D and adiponectin were inversely associated with type 2 diabetes and insulin resistance.
Vitamin D may involve in regulation of the adiponectin levels, which is directly related to insulin sensitivity. Objectives : The aim of this study was to investigate the effect of therapeutic dose of vitamin D on serum adiponectin and insulin resistance in vitamin D-insufficient or deficient type 2 diabetic patients. Materials and Methods : This double-blind, randomized, clinical trial was conducted on 81 type 2 diabetic patients with vitamin D level of 10-30 ng/mL.
Intervention was 50000 IU vitamin D or placebo once a week for 8 weeks.
At the beginning and end of the study, blood samples were collected after 12 hours of fasting and serum glucose, insulin, 25-hydroxyvitamin D, and adiponectin were measured.
Insulin resistance was calculated by homeostasis model assessment (HOMA-IR). Results : After 8-week intervention, serum 25-hydroxyvitamin D significantly increased and reached the normal levels in patients receiving vitamin D (P < 0.001) and the levels of fasting serum glucose, insulin, and HOMA-IR were significantly decreased (P = 0.04, 0.02 and 0.007, respectively).
No significant changes were observed in these levels in the placebo group.
Significant differences were observed in mean changes in the above-mentioned variables between the two groups (P = 0.01, 0.04 and 0.006, respectively).
No significant changes were found in serum adiponectin in the vitamin D and placebo groups (P = 0.83). Conclusions : Therapeutic dose of vitamin D can improve vitamin D status and glycemic indicators.
But it seems that an 8-week intervention period was not sufficient to reveal the possible effects of vitamin D on serum adiponectin levels.
American Psychological Association (APA)
Baziar, Nima& Jafarian, Kurosh& Shadman, Zhalah& Qurbani, Mustafa& Nikoo, Muhsin Khushniat& Abd Mishani, Mahshid. 2014. Effect of therapeutic dose of vitamin D on serum adiponectin and glycemia in vitamin D-insufficient or deficient type 2 diabetic Patients. Iranian Red Crescent Medical Journal،Vol. 16, no. 9, pp.1-8.
https://search.emarefa.net/detail/BIM-408236
Modern Language Association (MLA)
Baziar, Nima…[et al.]. Effect of therapeutic dose of vitamin D on serum adiponectin and glycemia in vitamin D-insufficient or deficient type 2 diabetic Patients. Iranian Red Crescent Medical Journal Vol. 16, no. 9 (Sep. 2014), pp.1-8.
https://search.emarefa.net/detail/BIM-408236
American Medical Association (AMA)
Baziar, Nima& Jafarian, Kurosh& Shadman, Zhalah& Qurbani, Mustafa& Nikoo, Muhsin Khushniat& Abd Mishani, Mahshid. Effect of therapeutic dose of vitamin D on serum adiponectin and glycemia in vitamin D-insufficient or deficient type 2 diabetic Patients. Iranian Red Crescent Medical Journal. 2014. Vol. 16, no. 9, pp.1-8.
https://search.emarefa.net/detail/BIM-408236
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 7-8
Record ID
BIM-408236